UB Paderborn / Katalog / Suche / in CDI

Adjustment for time-dependent unmeasured confounders in marginal structural Cox models using validation sample data

Statistical methods in medical research, 2019-02, Vol.28 (2), p.357-371

2019

Volltextzugriff (PDF)

Martingale residual-based method to control for confounders measured only in a validation sample in time-to-event analysis

Statistics in medicine, 2016-11, Vol.35 (25), p.4588-4606

2016

Volltextzugriff (PDF)

A Cluster-Randomized Trial to Reduce Cesarean Delivery Rates in Quebec

The New England journal of medicine, 2015-04, Vol.372 (18), p.1710-1721

2015

Volltextzugriff (PDF)

In-Hospital Therapy for Heart Failure With Reduced Ejection Fraction in the United States

JACC. Heart failure, 2020-11, Vol.8 (11), p.943-953

2020

Volltextzugriff (PDF)

Asthma is not associated with the need for surgery in Crohn's disease when controlling for smoking status: a population-based cohort study

Clinical epidemiology, 2018-01, Vol.10, p.831-840

2018

Volltextzugriff (PDF)

Adjuvant therapy versus watch-and-wait post surgery for stage III melanoma: a multicountry retrospective chart review

Melanoma management, 2019-12, Vol.6 (4), p.MMT33-MMT33

2019

Volltextzugriff (PDF)

Abstract PS10-29: Comparison of healthcare resource utilization and costs in women with HR+/HER2- metastatic breast cancer treated with ribociclib vs palbociclib or abemaciclib

Cancer research (Chicago, Ill.), 2021-02, Vol.81 (4_Supplement), p.PS10-29-PS10-29

2021

Volltextzugriff (PDF)

S1152 Emergency Department Utilization in Patients With Hepatic Encephalopathy (HE) Treated With Rifaximin (± Lactulose) versus Lactulose Alone

The American journal of gastroenterology, 2021-10, Vol.116 (1), p.S539-S539

2021

Volltextzugriff (PDF)

Su1860 – Comparison of Real-World Treatment Outcomes with Infliximab Versus Vedolizumab in Biologic-Naive Patients with Inflammatory Bowel Disease

Gastroenterology (New York, N.Y. 1943), 2019-05, Vol.156 (6), p.S-638-S-639

2019

Volltextzugriff (PDF)

Comparison of healthcare resource utilization and costs of patients with HR+/HER2- advanced breast cancer treated with ribociclib versus other CDK4/6 inhibitors

Journal of medical economics, 2021-01, Vol.24 (1), p.806-815

2021

Volltextzugriff (PDF)

Hospitalizations and healthcare costs associated with rifaximin versus lactulose treatment among commercially insured patients with hepatic encephalopathy in the United States

Journal of medical economics, 2021-01, Vol.24 (1), p.202-211

2021

Volltextzugriff (PDF)

Abstract 1206: Patterns of BRAF testing and treatment in patients with metastatic melanoma presumed BRAF positive

Cancer research (Chicago, Ill.), 2018-07, Vol.78 (13_Supplement), p.1206-1206

2018

Volltextzugriff (PDF)

Abstract 1209: Patterns of treatment with immune check point inhibitors and targeted therapy in patients with metastatic melanoma presumed BRAF V600 positive

Cancer research (Chicago, Ill.), 2018-07, Vol.78 (13_Supplement), p.1209-1209

2018

Volltextzugriff (PDF)

Abstract 4768: Characteristics of patients diagnosed de novo with AJCC7 stage III or regionally advanced cutaneous melanoma and trends in adjuvant therapy: An analysis of the SEER cancer registry in the United States

Cancer research (Chicago, Ill.), 2018-07, Vol.78 (13_Supplement), p.4768-4768

2018

Volltextzugriff (PDF)

Comparison of Real-World Treatment Outcomes With Vedolizumab Versus Infliximab in Biologic-Naive Patients With Inflammatory Bowel Disease

Crohn's & colitis 360, 2019-07, Vol.1 (2)

2019

Volltextzugriff (PDF)

Time to first-line (1L) therapy discontinuation in metastatic melanoma (MM)

Journal of clinical oncology, 2018-02, Vol.36 (5_suppl), p.196-196

2018

Volltextzugriff (PDF)

Healthcare resource utilization in patients with metastatic melanoma receiving first-line therapy with dabrafenib + trametinib versus nivolumab or pembrolizumab monotherapy

Current medical research and opinion, 2018-12, Vol.34 (12), p.2169-2176

2018

Volltextzugriff (PDF)

OUTCOMES ASSOCIATED WITH DIFFERENT TREATMENT PATTERNS AMONG PATIENTS HOSPITALIZED WITH ACUTE HEART FAILURE AND REDUCED EJECTION FRACTION IN THE UNITED STATES

Journal of the American College of Cardiology, 2019-03, Vol.73 (9), p.817-817

2019

Volltextzugriff (PDF)

Real-World Management of Patients with Newly Diagnosed Acute Myeloid Leukemia Treated with Venetoclax-Based Regimens: Results from the AML Real World Evidence (ARC) Initiative

Blood, 2021-11, Vol.138 (Supplement 1), p.1271-1271

2021

Volltextzugriff (PDF)

Asthma Is Not Associated With the Need for Surgery in Crohnʼs Disease When Controlling for Smoking Status: A Population-Based Cohort Study: 2717

The American journal of gastroenterology, 2017-10, Vol.112, p.S1476

2017

Volltextzugriff (PDF)

Postsurgical treatment landscape and economic burden of locoregional and distant recurrence in patients with operable nonmetastatic melanoma

Melanoma research, 2018-12, Vol.28 (6), p.618-628

2018

Volltextzugriff (PDF)

Abstract 1203: Incidence of AJCC7 stage III or regionally advanced cutaneous melanoma in the United States

Cancer research (Chicago, Ill.), 2018-07, Vol.78 (13_Supplement), p.1203-1203

2018

Volltextzugriff (PDF)

Quality of care, risk management, and technology in obstetrics to reduce hospital-based maternal mortality in Senegal and Mali (QUARITE): a cluster-randomised trial

The Lancet (British edition), 2013-07, Vol.382 (9887), p.146-157

2013

Volltextzugriff (PDF)

Stage III melanoma incidence and impact of transitioning to the 8th AJCC staging system: a US population-based study

Future oncology (London, England), 2019-02, Vol.15 (4), p.359-370

2019

Volltextzugriff (PDF)

Menü

Weitere Dienste

Einstellungen

Adjustment for time-dependent unmeasured confounders in marginal structural Cox models using validation sample data

Martingale residual-based method to control for confounders measured only in a validation sample in time-to-event analysis

A Cluster-Randomized Trial to Reduce Cesarean Delivery Rates in Quebec

In-Hospital Therapy for Heart Failure With Reduced Ejection Fraction in the United States

Asthma is not associated with the need for surgery in Crohn's disease when controlling for smoking status: a population-based cohort study

Adjuvant therapy versus watch-and-wait post surgery for stage III melanoma: a multicountry retrospective chart review

Abstract PS10-29: Comparison of healthcare resource utilization and costs in women with HR+/HER2- metastatic breast cancer treated with ribociclib vs palbociclib or abemaciclib

S1152 Emergency Department Utilization in Patients With Hepatic Encephalopathy (HE) Treated With Rifaximin (± Lactulose) versus Lactulose Alone

Su1860 – Comparison of Real-World Treatment Outcomes with Infliximab Versus Vedolizumab in Biologic-Naive Patients with Inflammatory Bowel Disease

Comparison of healthcare resource utilization and costs of patients with HR+/HER2- advanced breast cancer treated with ribociclib versus other CDK4/6 inhibitors

Hospitalizations and healthcare costs associated with rifaximin versus lactulose treatment among commercially insured patients with hepatic encephalopathy in the United States

Abstract 1206: Patterns of BRAF testing and treatment in patients with metastatic melanoma presumed BRAF positive

Abstract 1209: Patterns of treatment with immune check point inhibitors and targeted therapy in patients with metastatic melanoma presumed BRAF V600 positive

Abstract 4768: Characteristics of patients diagnosed de novo with AJCC7 stage III or regionally advanced cutaneous melanoma and trends in adjuvant therapy: An analysis of the SEER cancer registry in the United States

Comparison of Real-World Treatment Outcomes With Vedolizumab Versus Infliximab in Biologic-Naive Patients With Inflammatory Bowel Disease

Time to first-line (1L) therapy discontinuation in metastatic melanoma (MM)

Healthcare resource utilization in patients with metastatic melanoma receiving first-line therapy with dabrafenib + trametinib versus nivolumab or pembrolizumab monotherapy

OUTCOMES ASSOCIATED WITH DIFFERENT TREATMENT PATTERNS AMONG PATIENTS HOSPITALIZED WITH ACUTE HEART FAILURE AND REDUCED EJECTION FRACTION IN THE UNITED STATES

Real-World Management of Patients with Newly Diagnosed Acute Myeloid Leukemia Treated with Venetoclax-Based Regimens: Results from the AML Real World Evidence (ARC) Initiative

Comparative Effectiveness of Venetoclax Combinations Vs Other Therapies Among Patients with Newly Diagnosed Acute Myeloid Leukemia: Results from the AML Real World Evidence (ARC) Initiative

Asthma Is Not Associated With the Need for Surgery in Crohnʼs Disease When Controlling for Smoking Status: A Population-Based Cohort Study: 2717

Postsurgical treatment landscape and economic burden of locoregional and distant recurrence in patients with operable nonmetastatic melanoma

Abstract 1203: Incidence of AJCC7 stage III or regionally advanced cutaneous melanoma in the United States

Quality of care, risk management, and technology in obstetrics to reduce hospital-based maternal mortality in Senegal and Mali (QUARITE): a cluster-randomised trial

Stage III melanoma incidence and impact of transitioning to the 8th AJCC staging system: a US population-based study

Aktive Filter

Suchergebnisse filtern